Dynamic alterations of connexin43, matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 during ventricular fibrillation in canine

[1]  Xianghong Wu,et al.  Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling , 2013, Molecular and Cellular Biochemistry.

[2]  Yijiang Chen,et al.  CX43 change in LPS preconditioning against apoptosis of mesenchymal stem cells induced by hypoxia and serum deprivation is associated with ERK signaling pathway , 2013, Molecular and Cellular Biochemistry.

[3]  Xianxu Zeng,et al.  AP-2α suppresses invasion in BeWo cells by repression of matrix metalloproteinase-2 and -9 and up-regulation of E-cadherin , 2013, Molecular and Cellular Biochemistry.

[4]  Robert N. Taylor,et al.  Retinoic acid regulates gap junction intercellular communication in human endometrial stromal cells through modulation of the phosphorylation status of connexin 43 , 2013, Journal of cellular physiology.

[5]  K. Tanriverdi,et al.  Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis , 2013, Journal of the American Heart Association.

[6]  J. Moffitt,et al.  Hindlimb unloading results in increased predisposition to cardiac arrhythmias and alters left ventricular connexin 43 expression. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  S. Davidge,et al.  Matrix Metalloproteinase Enhances Big-Endothelin-1 Constriction in Mesenteric Vessels of Pregnant Rats With Reduced Uterine Blood Flow , 2013, Hypertension.

[8]  Yun Zhang,et al.  Imbalance between tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 after cardiopulmonary resuscitation. , 2012, The American journal of emergency medicine.

[9]  R. Sarkar,et al.  Matrix metalloproteinases in vascular physiology and disease , 2012, Vascular.

[10]  A. Xue,et al.  MicroRNA- 1 represses Cx43 expression in viral myocarditis , 2012, Molecular and Cellular Biochemistry.

[11]  V. Belo,et al.  Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome , 2011, Molecular and Cellular Biochemistry.

[12]  R. Hauer,et al.  The role of connexin40 in atrial fibrillation. , 2009, Cardiovascular research.

[13]  P. Lampe,et al.  Connexin43 phosphorylation: structural changes and biological effects. , 2009, The Biochemical journal.

[14]  M. Sugimachi,et al.  Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit. , 2007, American journal of physiology. Heart and circulatory physiology.

[15]  P. Schauerte,et al.  Decreased Plasminogen Activator Inhibitor and Tissue Metalloproteinase Inhibitor Expression May Promote Increased Metalloproteinase Activity with Increasing Duration of Human Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[16]  R. Levine,et al.  Early Repair of Moderate Ischemic Mitral Regurgitation Reverses Left Ventricular Remodeling: A Functional and Molecular Study , 2007, Circulation.

[17]  Jing-quan Zhong,et al.  Effects of Rotigaptide, a Gap Junction Modifier, on Defibrillation Energy and Resuscitation From Cardiac Arrest in Rabbits , 2007, Journal of cardiovascular pharmacology and therapeutics.

[18]  Jing-quan Zhong,et al.  Changes in connexin 43, metalloproteinase and tissue inhibitor of metalloproteinase during tachycardia‐induced cardiomyopathy in dogs , 2007, European journal of heart failure.

[19]  Leslie L. Clark,et al.  Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases: Relationship Between Changes in Proteolytic Determinants of Matrix Composition and Structural, Functional, and Clinical Manifestations of Hypertensive Heart Disease , 2006, Circulation.

[20]  R. Schaub,et al.  Rotigaptide (ZP123) Prevents Spontaneous Ventricular Arrhythmias and Reduces Infarct Size During Myocardial Ischemia/Reperfusion Injury in Open-Chest Dogs , 2006, Journal of Pharmacology and Experimental Therapeutics.

[21]  K. Webster,et al.  Reversible Connexin 43 Dephosphorylation During Hypoxia and Reoxygenation Is Linked to Cellular ATP Levels , 2004, Circulation research.

[22]  Arantxa González,et al.  Role of matrix metalloproteinases in hypertension-associated cardiac fibrosis , 2004, Current opinion in nephrology and hypertension.

[23]  M. Bennett,et al.  Gating and regulation of connexin 43 (Cx43) hemichannels , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Michael D. Schneider,et al.  Conduction Slowing and Sudden Arrhythmic Death in Mice With Cardiac-Restricted Inactivation of Connexin43 , 2001, Circulation research.

[25]  J E Saffitz,et al.  Dephosphorylation and Intracellular Redistribution of Ventricular Connexin43 During Electrical Uncoupling Induced by Ischemia , 2000, Circulation research.

[26]  Yang Zheng,et al.  The effects of high-dose epinephrine combined with isoprenaline on isolated rabbit heart and cardiomyocytes after cardioversion of ventricular fibrillation , 2000, Molecular and Cellular Biochemistry.

[27]  K. A. Yamada,et al.  Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. , 2000, Circulation.

[28]  M. Radomski,et al.  Release of gelatinase A during platelet activation mediates aggregation , 1997, Nature.

[29]  N. Tribulova,et al.  Adaptation of the heart to hypertension is associated with maladaptive gap junction connexin-43 remodeling. , 2008, Physiological research.

[30]  N. Tribulova,et al.  Myocardial gap junctions: targets for novel approaches in the prevention of life-threatening cardiac arrhythmias. , 2008, Physiological research.

[31]  I. Imanaga,et al.  Remodelling of cardiac gap junction connexin 43 and arrhythmogenesis. , 2007, Experimental and clinical cardiology.

[32]  M. Lalu,et al.  Ischaemia-reperfusion injury activates matrix metalloproteinases in the human heart. , 2005, European heart journal.

[33]  N. Tribulova,et al.  Gap junction remodelling is involved in the susceptibility of diabetic rats to hypokalemia-induced ventricular fibrillation. , 2002, Acta histochemica.